PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Dec-2022 Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing A*STAR
06-Dec-2022 MHRA Innovation Passport awarded to Boehringer Ingelheim’s investigational treatment in aggressive and rare cancer Boehringer Ingelheim
06-Dec-2022 MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease Sciad Newswire
06-Dec-2022 Defence Therapeutics Inc.: DEFENCE POSITIONED TO BEGIN ITS ANTI-CANCER ACCUTOXTM PHASE I TRIAL WITH SUCCESSFUL COMPLETION OF GLP STUDIES Defence Therapeutics Inc.
06-Dec-2022 Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5 Kinarus Therapeutics Holding AG
05-Dec-2022 Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company Fresenius SE & Co. KGaA
05-Dec-2022 Fresenius Medical Care AG & Co. KGaA: Helen Giza to take over as Chief Executive Officer of Fresenius Medical Care Fresenius Medical Care AG & Co. KGaA
05-Dec-2022 Fresenius Medical Care AG & Co. KGaA: Ms. Helen Giza appointed as new CEO of the Management Board; Dr. Carla Kriwet agreed to resign as CEO and member of the Management Board Fresenius Medical Care AG & Co. KGaA
05-Dec-2022 PharmiWeb.Jobs Announces New Partnership With PCMG PharmiWeb.Jobs
05-Dec-2022 Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022 Sciad Newswire
02-Dec-2022 PolyPeptide provides market update PolyPeptide
01-Dec-2022 NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE STRATEC SE
01-Dec-2022 Nass Valley Gardens Announces It Has Contracted Its Reg A+ Capital Raise Team Nass Valley Gateway Ltd.
01-Dec-2022 Change in the Management of CHEPLAPHARM Cheplapharm AG
01-Dec-2022 BRIM Biotechnology, Inc. raises $20 million in Series E funding round Sciad Newswire
01-Dec-2022 BIOPHYTIS ORGANISES A WEBCAST WITH KEY OPINION LEADERS (KOL) ON THE PHASE 2-3 COVA STUDY RESULTS OF SARCONEOS (BIO101) IN THE TREATMENT OF PNEUMONIA IN COVID-19 PATIENTS AT RISK OF RESPIRAT Biophytis
01-Dec-2022 Portfolio company Lysatpharma and joint venture Novaxomx start with research and product development in biosurgical treatment therapies Xlife Sciences AG
30-Nov-2022 PAION AG announces change in Management Board PAION AG
30-Nov-2022 PAION AG: CEO Dr. James Phillips leaves the Company as of 30 November 2022, appointment of Supervisory Board member Gregor Siebert as member and new CEO until 30 November 2023 PAION AG
29-Nov-2022 Vetter-Hackathon 2022: Innovation Booster Through Employee Participation B3C newswire